Diligence memo · auto-generated · as of July 2, 2026
Octeta Therapeutics, LLC
Octeta Therapeutics, LLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Octeta Therapeutics, LLC operates in Biotechnology, based in KALAMAZOO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Octeta Therapeutics, LLC has raised $16M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $16M on 2016-05-05.
Most recent recorded round closed around 2016-05-05.
Valuation (modeled)modeled
Provath models Octeta Therapeutics, LLC at approximately $651M (range $33M–$2.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.82× the median modeled value of Series B Biotechnology companies in 2016–2018 (101 peers) — value vs value, same stage and era. Within the normal band (82% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 10.2 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 65% of Biotechnology peers (4293 compared).
Modeled value ranks above 85% of those peers.
Closest niche peers: Liquid BioScience, Inc., Amphivena Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Tetra Discovery Partners, Inc., ECM Therapeutics, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.